Abnormal expression or mutations of KLF5 have been implicated in the development and progression of several types of human cancer, including breast cancer,5 gastric cancer,34 colorectal cancer,7 pancreatic cancer35 and lung cancer.10 Here, KLF5 is linked to breast carcinoma.